The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: sandostatin     Quarter: 2016Q3

Total Records: 2,045     Number of Pages: 103

DRUGNAME PT EventCount
SANDOSTATIN LAR DEPOT Injection site rash 1
SANDOSTATIN LAR DEPOT Injection site scab 1
SANDOSTATIN LAR DEPOT Injury associated with device 1
SANDOSTATIN LAR DEPOT Internal haemorrhage 1
SANDOSTATIN LAR DEPOT International normalised ratio abnormal 1
SANDOSTATIN LAR DEPOT International normalised ratio fluctuation 1
SANDOSTATIN LAR DEPOT Intervertebral disc disorder 1
SANDOSTATIN LAR DEPOT Intracranial mass 1
SANDOSTATIN LAR DEPOT Intracranial pressure increased 1
SANDOSTATIN LAR DEPOT Intraocular pressure increased 1
SANDOSTATIN LAR DEPOT Irritable bowel syndrome 1
SANDOSTATIN LAR DEPOT Joint effusion 1
SANDOSTATIN LAR DEPOT Lipase increased 1
SANDOSTATIN LAR DEPOT Liquid product physical issue 1
SANDOSTATIN LAR DEPOT Liver function test increased 1
SANDOSTATIN LAR DEPOT Liver induration 1
SANDOSTATIN LAR DEPOT Localised oedema 1
SANDOSTATIN LAR DEPOT Lumbar vertebral fracture 1
SANDOSTATIN LAR DEPOT Lymphocyte count decreased 1
SANDOSTATIN LAR DEPOT Malignant melanoma 1

Total Records: 2,045     Number of Pages: 103